24 publications
| Name | Date | Type | Actions |
|---|---|---|---|
Monthly information regarding the total number of voting rights and shares making of the share capital - November2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
14/12/2011 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - October 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
09/11/2011 | Voting rights | |
Q3 2011 Sales Vétoquinol achieved Q3 2011 sales of €68.4 million, in line with the previous year. |
25/10/2011 | Public releases | |
Jacques du Puy appointed Vétoquinol Managing Director Lure (France), October 12, 2011 – The Vétoquinol Group announces the appointment |
12/10/2011 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - September 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
07/10/2011 | Voting rights | |
Forcyl®: european launch of new drug Lure (France), September 29, 2011 – Vétoquinol announces the European launch of Forcyl®, a new drug based on 16% concentrated marbofloxacin allowing the treatment of cattle respiratory infections with a single injection. |
29/09/2011 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - August 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
07/09/2011 | Voting rights | |
Monthly information regarding the total number of voting rights and shares making of the share capital - July 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
07/09/2011 | Voting rights | |
Vétoquinol continues to develop its product ranges and enters the brazilian market Lure (France), August 30, 2011 – The Vetoquinol Board Meeting of August 29, 2011 reviewed the Group’s business and approved the financial statements for the first half 2011. |
30/08/2011 | Public releases | |
International expansion and new product launches Lure (France), July 19, 2011 – Vétoquinol Group sales rose to €139.7 million in the first six months of 2011. |
19/07/2011 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - June 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
08/07/2011 | Voting rights | |
European launch of new Nsaid Cimalgex® Lure (France), June 14, 2011 – Vetoquinol announces the European launch of CIMALGEX®, a new treatment for pain and inflammation in dogs. |
14/06/2011 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - May 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
08/06/2011 | Voting rights | |
VÉTOQUINOL enters the brazilian Market Lure (France), June 7, 2011 – Vetoquinol announces the acquisition of 100% of the equity of Farmagricola SA in Brazil. |
07/06/2011 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - April 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
09/05/2011 | Voting rights | |
Vetoquinol publishes its registration document and its annual financial report relative to fiscal year 2010 (french version) The registration document of Vétoquinol relative to fiscal year 2010, including the annual financial report relative to fiscal year 2010, was registered with the Autorité des marchés financiers (“the AMF”) on April 18th, 2011. |
27/04/2011 | Public releases | |
Net Sales rise 3% to €66.4 Million in the first Quarter of 2011 The Vétoquinol group reported a 3.0% rise in first quarter 2011 net sales to €66.4 million, compared to the same period last year. |
19/04/2011 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - March 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
12/04/2011 | Voting rights | |
2010 annual earnings Lure (France), April 4, 2011 – Vétoquinol’s Board of Directors, meeting on March 18, 2011, has reviewed the Group’s business and approved its 2010 financial statements. |
04/04/2011 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - February2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
07/03/2011 | Voting rights | |
Redemption of tranche B bonds Lure, 28 February 2011 – Vétoquinol S.A. has announced the redemption of the 58,927 tranche B bonds reaching maturity on 27 February 2011, by their conversion into common shares. |
28/02/2011 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - January 2011 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
09/02/2011 | Voting rights | |
2010 Revenues grow 11.8%, driven by organic growth The Vétoquinol Group reports sustained sales growth driven by its “hybrid” business model, supported by a sound level of organic growth. |
25/01/2011 | Public releases | |
Monthly information regarding the total number of voting rights and shares making of the share capital - December 2010 As per article 223.16 of the « Règlement Général de l’Autorité des Marchés Financiers » |
10/01/2011 | Voting rights |